Cargando…

Usefulness of LDAEP to Predict Tolerability to SSRIs in Major Depressive Disorder: A Case Report

We report here a patient with major depressive disorder who experienced severe adverse effects after the administration of SSRIs (serotonin selective reuptake inhibitors) without improvement of his depressive symptoms. These adverse effects disappeared and his depressive symptoms improved after disc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Young-Min, Lee, Seung-Hwan, Park, Eun Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neuropsychiatric Association 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285746/ https://www.ncbi.nlm.nih.gov/pubmed/22396689 http://dx.doi.org/10.4306/pi.2012.9.1.80

Ejemplares similares

Prediction of Long-Term Treatment Response to Selective Serotonin Reuptake Inhibitors (SSRIs) Using Scalp and Source Loudness Dependence of Auditory Evoked Potentials (LDAEP) Analysis in Patients with Major Depressive Disorder
por: Lee, Bun-Hee, et al.
Publicado: (2015)

Clinical Usefulness of Loudness Dependence of Auditory Evoked Potentials (LDAEP) in Patients with Bipolar Disorder
por: Park, Young-Min, et al.
Publicado: (2013)

Resveratrol supplementation enhanced SSRIs efficacy in premenopausal women with major depressive disorder
por: Fedotova, J., et al.
Publicado: (2023)

Effect of SSRIs on Resting-State Functional Brain Networks in Adolescents with Major Depressive Disorder
por: Chu, Shu-Hsien, et al.
Publicado: (2021)

Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder
por: Lundberg, Johan, et al.
Publicado: (2012)

Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding
por: Lee, Min-Taek, et al.
Publicado: (2020)

A MRS study of metabolic alterations in the frontal white matter of major depressive disorder patients with the treatment of SSRIs
por: Zhang, Yifan, et al.
Publicado: (2015)

Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder
por: Liu, Xianchen, et al.
Publicado: (2011)

Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder
por: Zhang, Aixia, et al.
Publicado: (2022)

Association between Cortical GABA and Loudness Dependence of Auditory Evoked Potentials (LDAEP) in Humans
por: Wyss, Christine, et al.
Publicado: (2018)

The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
por: Fugger, Gernot, et al.
Publicado: (2022)

Data on the impact of SSRIs and depression symptoms on the neural activities in obsessive–compulsive disorder at rest
por: Chen, Yunhui, et al.
Publicado: (2016)

Association between increased serum interleukin-8 levels and improved cognition in major depressive patients with SSRIs
por: Cai, Yuan, et al.
Publicado: (2023)

TED—trazodone effectiveness in depression: a naturalistic study of the effeciveness of trazodone in extended release formulation compared to SSRIs in patients with a major depressive disorder
por: Dudek, Dominika, et al.
Publicado: (2023)

The Loudness Dependence of Auditory Evoked Potentials (LDAEP) as an Indicator of Serotonergic Dysfunction in Patients with Predominant Schizophrenic Negative Symptoms
por: Wyss, Christine, et al.
Publicado: (2013)

Repeated use of SSRIs potentially associated with an increase on serum CK and CK-MB in patients with major depressive disorder: a retrospective study
por: Wu, Shengwei, et al.
Publicado: (2021)

P.0403 Disticnt effects of SSRIs therapy in patients with the first episode of major depressive disorder/generalized anxiety disorder after COVID-19 disease
por: Bereza, Z., et al.
Publicado: (2021)

Placental serotonin: implications for the developmental effects of SSRIs and maternal depression
por: Velasquez, Juan C., et al.
Publicado: (2013)

Pharmacogenetics of SSRIs and Sexual Dysfunction
por: Osis, Liana, et al.
Publicado: (2010)

Comparisons of Serum Interleukin-8 Levels in Major Depressive Patients With Drug-Free Versus SSRIs Versus Healthy Controls
por: Zhu, Zhen Hua, et al.
Publicado: (2022)

Acupuncture combined with SSRIs in the treatment of perimenopausal depressive disorder: A protocol for systematic review and meta-analysis
por: Gao, Zhan, et al.
Publicado: (2022)

Duloxetine-Induced Liver Injury in Patients with Major Depressive Disorder
por: Kang, Seung-Gul, et al.
Publicado: (2011)

SSRIs treatment did not completely restore affective state in patients with the initial clinically confirmed major depressive disorder/generalized anxiety disorder after COVID-19 disease
por: Fedotova, J., et al.
Publicado: (2022)

Dienogest-induced major depressive disorder with suicidal ideation: A case report
por: Lee, Sang Min, et al.
Publicado: (2021)

Type-D Personality Can Predict Suicidality in Patients with Major Depressive Disorder
por: Park, Young-Min, et al.
Publicado: (2014)

Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Cholestatic Jaundice Induced by Duloxetine in a Patient with Major Depressive Disorder
por: Park, Young-Min, et al.
Publicado: (2010)

Frontal Alpha Asymmetry Correlates with Suicidal Behavior in Major Depressive Disorder
por: Park, Yeonsoo, et al.
Publicado: (2019)

Serum Levels of Tumor Necrosis Factor-α and Loudness Dependence of Auditory Evoked Potentials at Pretreatment and Posttreatment in Patients with Major Depressive Disorder
por: Lee, Bun-Hee, et al.
Publicado: (2019)

Antidepressants: From MAOIs to SSRIs and more
por: Ramachandraih, Chaitra T., et al.
Publicado: (2011)

Continuing medical education: SSRIs and pregnancy
por: Andrade, Chittaranjan
Publicado: (2010)

Serotonin syndrome: SSRIs are not the only culprit
por: Garel, Nicolas, et al.
Publicado: (2021)

Machine-learning-based classification between post-traumatic stress disorder and major depressive disorder using P300 features
por: Shim, Miseon, et al.
Publicado: (2019)

Is the total score of the Hamilton Depression Rating Scale affected by side effects of SSRIs and SNRIs?
por: Østergaard, S. D.
Publicado: (2023)

Neuroimaging Biomarkers for Predicting Treatment Response and Recurrence of Major Depressive Disorder
por: Kang, Seung-Gul, et al.
Publicado: (2020)

Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial
por: Shim, Se-hoon, et al.
Publicado: (2022)

Exploring new frontiers in neuropsychopharmacology: SSRIs for stroke
por: Sathyanarayana Rao, T. S., et al.
Publicado: (2011)

Treatment of 95 post-Covid patients with SSRIs
por: Rus, Carla P., et al.
Publicado: (2023)

SUMOylation and Major Depressive Disorder
por: Jeoung, Seok-Won, et al.
Publicado: (2022)

Final validation of the mental health screening tool for depressive disorders: A brief online and offline screening tool for major depressive disorder
por: Park, Kiho, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_deq0116u6c1aq85t1a3lol8rqo